Jeffrey Cohen talks to us about proposed new updates to the McDonald criteria for MS diagnosis.
1. Why are revisions to the McDonald criteria needed? (0:05)
2. What are the limitations of the current criteria in special populations (i.e. paediatric, Asian and Latin American people)? (0:38)
3. What revisions have been proposed to the definition of MS phenotypes? (1:11)
4. How have the revisions reflected the increased value of CSF in diagnosis of MS? (2:23)
5. What revisions have been made to the MRI criteria for the diagnosis of MS? (3:46)
Speaker disclosures: Jeffrey Cohen serves as a consultant to Adamas and Celgene, and as Co-Editor of Multiple Sclerosis Journal – Experimental, Translational and Clinical.
Filmed at the 7th Joint ECTRIMS-ACTRIMS Meeting, Paris, France, October 2017.
